You just read:

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan

News provided by

Regeneron Pharmaceuticals, Inc.

Jul 05, 2016, 01:00 ET